Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare Investment Banking Group

Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare
                           Investment Banking Group

PR Newswire

NEW YORK, June 12, 2014

NEW YORK, June 12, 2014 /PRNewswire/ -- Guggenheim Securities, the investment
banking and capital markets division of Guggenheim Partners, today announced
the hiring of Barry Blake as a Senior Managing Director. Mr. Blake will focus
on advising healthcare services companies and will commence work at Guggenheim
in September 2014.

"We are very pleased to welcome Barry to the team," said Mark Van Lith, Head
of Investment Banking at Guggenheim Securities. "Barry is a trusted adviser to
his clients. Barry's strong relationships and deep sector expertise will
contribute meaningfully to our healthcare franchise."

Most recently, Mr. Blake was the Head of Global Healthcare Mergers and
Acquisitions for Citigroup. Prior to that, he was in the M&A and Healthcare
groups at JP Morgan and Lehman Brothers.

Mr. Blake has extensive relationships and experience in healthcare services.
His recent transaction experienceincludes: Express-Scripts acquisition of
Medco, Amsurg's acquisition of Sheridan Healthcare, the sale of Rehabcare
Group to Kindred Healthcare, and Labcorp's acquisition of Genzyme Genetics.

Mr. Blake received his BS from Hendrix College and his MBA from Tuck School of

About Guggenheim Partners

Guggenheim Partners is a privately held global financial services firm with
more than $210 billion in assets under management. The firm provides asset
management, investment banking and capital markets services, insurance
services, institutional finance and investment advisory solutions to
institutions, governments and agencies, corporations, investment advisors,
family offices and individuals. Guggenheim Partners is headquartered in New
York and Chicago and serves clients around the world from more than 25 offices
in eight countries. For more information about Guggenheim Partners, visit

SOURCE Guggenheim Partners

Contact: Thomas S. Mulligan, Sitrick And Company, 310.367.6567,; Terry Fahn, Sitrick And Company, 310.788.2850,
Press spacebar to pause and continue. Press esc to stop.